Bao R - Search Results

1

The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.

Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, Luke JJ, Gajewski TF. Matson V, et al. Among authors: bao r. Science. 2018 Jan 5;359(6371):104-108. doi: 10.1126/science.aao3290. Science. 2018. PMID: 29302014 Free PMC article.

2

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.

Spranger S, Bao R, Gajewski TF. Spranger S, et al. Among authors: bao r. Nature. 2015 Jul 9;523(7559):231-5. doi: 10.1038/nature14404. Epub 2015 May 11. Nature. 2015. PMID: 25970248

3

Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.

Sweis RF, Spranger S, Bao R, Paner GP, Stadler WM, Steinberg G, Gajewski TF. Sweis RF, et al. Among authors: bao r. Cancer Immunol Res. 2016 Jul;4(7):563-8. doi: 10.1158/2326-6066.CIR-15-0274. Epub 2016 May 17. Cancer Immunol Res. 2016. PMID: 27197067 Free PMC article.

4

Clinical Response of a Patient to Anti-PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors.

Shah S, Ward JE, Bao R, Hall CR, Brockstein BE, Luke JJ. Shah S, et al. Among authors: bao r. Cancer Immunol Res. 2016 Nov;4(11):903-909. doi: 10.1158/2326-6066.CIR-16-0087. Epub 2016 Sep 16. Cancer Immunol Res. 2016. PMID: 27638840 Free PMC article.

5

Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.

Spranger S, Luke JJ, Bao R, Zha Y, Hernandez KM, Li Y, Gajewski AP, Andrade J, Gajewski TF. Spranger S, et al. Among authors: bao r. Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7759-E7768. doi: 10.1073/pnas.1609376113. Epub 2016 Nov 11. Proc Natl Acad Sci U S A. 2016. PMID: 27837020 Free PMC article.

6

Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer.

Shah S, Wood K, Labadie B, Won B, Brisson R, Karrison T, Hensing T, Kozloff M, Bao R, Patel JD, Luke JJ. Shah S, et al. Among authors: bao r. Oncotarget. 2017 Dec 15;9(4):4375-4384. doi: 10.18632/oncotarget.23315. eCollection 2018 Jan 12. Oncotarget. 2017. PMID: 29435109 Free PMC article.

7

T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection.

Trujillo JA, Sweis RF, Bao R, Luke JJ. Trujillo JA, et al. Among authors: bao r. Cancer Immunol Res. 2018 Sep;6(9):990-1000. doi: 10.1158/2326-6066.CIR-18-0277. Cancer Immunol Res. 2018. PMID: 30181337 Free PMC article.

8

Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.

Labadie BW, Bao R, Luke JJ. Labadie BW, et al. Among authors: bao r. Clin Cancer Res. 2019 Mar 1;25(5):1462-1471. doi: 10.1158/1078-0432.CCR-18-2882. Epub 2018 Oct 30. Clin Cancer Res. 2019. PMID: 30377198 Free PMC article. Review.

9

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.

Luke JJ, Bao R, Sweis RF, Spranger S, Gajewski TF. Luke JJ, et al. Among authors: bao r. Clin Cancer Res. 2019 May 15;25(10):3074-3083. doi: 10.1158/1078-0432.CCR-18-1942. Epub 2019 Jan 11. Clin Cancer Res. 2019. PMID: 30635339 Free PMC article.

10

Response to Anti-PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis.

Johnson DB, Bao R, Ancell KK, Daniels AB, Wallace D, Sosman JA, Luke JJ. Johnson DB, et al. Among authors: bao r. J Natl Compr Canc Netw. 2019 Feb;17(2):114-117. doi: 10.6004/jnccn.2018.7070. J Natl Compr Canc Netw. 2019. PMID: 30787124 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

801 results

Search Page

Filters